Genelux Investor Presentation Deck
Accomplished Clinical Advisory Board
Medical Director,
Gynecologic
Oncology,
AdventHealth
Cancer Institute
Chief Medical
Officer, Vanium
Group
Co-Director,
Gynecologic
Oncology, Hoag
Memorial Hospital
Presbyterian
Deputy Director of
the University of
Cincinnati Cancer
Institute
Professor and
Division Director,
Ohio State
University
Comprehensive
Cancer Center
Forsythe & Bear,
LLC
GENELUX
Robert Holloway, MD
CHAIRMAN
Robert Coleman, MD
Member
Albert A. Mendivil, MD
Member
Thomas J. Herzog, MD
Chief Executive Officer
David M. O'Malley, MD
Chief Medical Officer
Alan Forsythe, PhD
Chief Financial Officer
Dr. Holloway is the principal investigator for VIRO-15 and has served on several committees of the Society
of Gynecologic Oncology (SGO), including its Board of Directors.
Dr. Coleman currently serves on the Board of Directors of Gynecologic Oncology Group and is co-Director of
GOG-Partners. In addition, he is immediate Past-President of the International Gynecologic Cancer Society.
Dr. Mendivil, site principal investigator for VIRO-15, serves as Co-Director of Gyn- Onc and Complex Pelvic
Surgery, Hoag Hospital. He has been the principal investigator or site sub-investigator on 20+ clinical trials.
Dr. Herzog is President-Elect of the GOG Foundation. He has served on the leadership board or council of
SGO, the Foundation for Women's Cancer, and ACOG.
Dr. O'Malley is the clinical trial advisor/lead for ovarian cancer within GOG Partners, a committee member
for the NCI Gynecologic Cancer Steering Committee's Ovarian Task Force and the NRG Oncology.
Dr. Forsythe has had a distinguished career in pharmaceutical drug development. As Vice President of
Corporate Biomedical Information at Amgen, Alan led the Biostatistics, Epidemiology and HOER depts.
34View entire presentation